Comment on Tadrous et al.: comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis.

Comment on Tadrous et al.: comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis.

書誌詳細
主要な著者:	Pazianas, M, Abrahamsen, B
フォーマット:	Journal article
言語:	English
出版事項:	2014

類似資料

Safety issues with bisphosphonate therapy for osteoporosis.
著者:: Suresh, E, 等
出版事項: (2014)

Safety of bisphosphonates.
著者:: Pazianas, M, 等
出版事項: (2011)

Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis.
著者:: Pazianas, M, 等
出版事項: (2010)

Inflammatory eye reactions in patients treated with bisphosphonates and other osteoporosis medications: cohort analysis using a national prescription database.
著者:: Pazianas, M, 等
出版事項: (2013)

Eliminating the need for fasting with oral administration of bisphosphonates.
著者:: Pazianas, M, 等
出版事項: (2013)

Bisphosphonates and colon cancer: reply.
著者:: Pazianas, M, 等
出版事項: (2013)

Bisphosphonates and colon cancer: Reply
著者:: Pazianas, M, 等
出版事項: (2013)

Findings of Danish study on risk of colon cancer in bisphosphonate users were misinterpreted.
著者:: Abrahamsen, B, 等
出版事項: (2013)

Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
著者:: Jiaqi Wu, 等
出版事項: (2018-08-01)

Safety and efficacy of bisphosphonates in thalassemia patients with osteopenia/osteoporosis
著者:: Sujata Sharma, 等
出版事項: (2023-04-01)

The therapeutic effect to eldecalcitol + bisphosphonate is superior to bisphosphonate alone in the treatment of osteoporosis: a meta-analysis
著者:: Zaoqian Zheng, 等
出版事項: (2020-09-01)

The art of treating osteoporosis: Bisphosphonates
著者:: Sergey Olegovich Mazurenko
出版事項: (2012-03-01)

Intravenous bisphosphonates for postmenopausal osteoporosis
著者:: Peyman Mottaghi
出版事項: (2010-01-01)

Correction to: The therapeutic effect to eldecalcitol + bisphosphonate is superior to bisphosphonate alone in the treatment of osteoporosis: a meta-analysis
著者:: Zaoqian Zheng, 等
出版事項: (2020-09-01)

Efficacy and safety of bisphosphonates on childhood osteoporosis secondary to chronic illness or its treatment: a meta-analysis
著者:: Huawei Zhao, 等
出版事項: (2022-10-01)

Additional effects of herbal medicine combined with bisphosphonates for primary osteoporosis: a systematic review and meta-analysis
著者:: Young-Seo Yoo, 等
出版事項: (2024-09-01)

Bisphosphonates and bone quality.
著者:: Pazianas, M, 等
出版事項: (2014)

Comparison of teriparatide and bisphosphonate in the treatment of postmenopausal osteoporosis: A meta-analysis
著者:: Yudong Li, 等
出版事項: (2025-01-01)

Evaluating the antifracture efficacy of bisphosphonates.
著者:: Pazianas, M, 等
出版事項: (2009)

A reappraisal of generic bisphosphonates in osteoporosis.
著者:: Kanis, J, 等
出版事項: (2012)

The use of bisphosphonates for the treatment and prevention of osteoporosis
著者:: O. A. Nikitinskaya, 等
出版事項: (2022-08-01)

Atrial fibrillation and bisphosphonate therapy.
著者:: Pazianas, M, 等
出版事項: (2010)

A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
著者:: Pazianas, M, 等
出版事項: (2007)

Oral Treatment With Bisphosphonates of Osteoporosis Does Not Increase the Risk of Severe Gastrointestinal Side Effects: A Meta-Analysis of Randomized Controlled Trials
著者:: Zsuzsa Réka Dömötör, 等
出版事項: (2020-11-01)

Reduced colon cancer incidence and mortality in postmenopausal women treated with an oral bisphosphonate--Danish National Register Based Cohort Study.
著者:: Pazianas, M, 等
出版事項: (2012)

Potential therapeutic effects of oral bisphosphonates on the intestine.
著者:: Pazianas, M, 等
出版事項: (2011)

Efficacy and safety of denosumab and teriparatide versus oral bisphosphonates to treat postmenopausal osteoporosis: a systematic review and meta-analysis
著者:: Jia Yang, 等
出版事項: (2024-09-01)

Long-term consequences of osteoporosis therapy with bisphosphonates
著者:: Bárbara Gehrke, 等
出版事項: (2023-11-01)

Are bisphosphonates associated with an increased risk of atypical femoral fractures as a class?
著者:: Pazianas, M
出版事項: (2013)

NE‐58025: A bisphosphonate with a low hydroxyapatite binding affinity
著者:: Michael Pazianas
出版事項: (2021-08-01)

Incidence of fractures of the femur, including subtrochanteric, up to 8 years since initiation of oral bisphosphonate therapy: a register-based cohort study using the US MarketScan claims databases.
著者:: Pazianas, M, 等
出版事項: (2012)

Changes in the utilization of osteoporosis drugs after the 2010 FDA bisphosphonate drug safety communication
著者:: Bander Balkhi, 等
出版事項: (2018-02-01)

The efficacy and safety of denosumab in postmenopausal women with osteoporosis previously treated with bisphosphonates: A review
著者:: Yilin Zhu, 等
出版事項: (2020-05-01)

Denosumab, teriparatide and bisphosphonates for glucocorticoid-induced osteoporosis: a Bayesian network meta-analysis
著者:: Liang Dong, 等
出版事項: (2024-01-01)

Atrial fibrillation and the use of oral bisphosphonates
著者:: Michael Pazianas, 等
出版事項: (2011-03-01)

glucocorticoid osteoporosis; osteoporotic fracture; bisphosphonates; FRAX algorithm
著者:: Natalia Vladimirovna Toroptsova, 等
出版事項: (2013-12-01)

Efficacy of Bisphosphonates for the Treatment of Osteoporosis in Patients with Multiple Sclerosis
著者:: İlke Coşkun Benlidayı, 等
出版事項: (2015-08-01)

glucocorticoid osteoporosis; osteoporotic fracture; bisphosphonates; FRAX algorithm
著者:: Natalia Vladimirovna Toroptsova, 等
出版事項: (2013-12-01)

Association between the use of serotonin receptor 2A-blocking antidepressants and joint disorders: comment on the article by Kling et al.
著者:: Pazianas, M
出版事項: (2010)

Atrial fibrillation and the use of oral bisphosphonates.
著者:: Pazianas, M, 等
出版事項: (2011)